Literature DB >> 24134622

Hypoxia, leptin, and vascular endothelial growth factor stimulate vascular endothelial cell differentiation of human adipose tissue-derived stem cells.

Mohamed M Bekhite1, Andreas Finkensieper, Jennifer Rebhan, Stephanie Huse, Stefan Schultze-Mosgau, Hans-Reiner Figulla, Heinrich Sauer, Maria Wartenberg.   

Abstract

The plasticity of human adipose tissue-derived stem cells (hASCs) is promising, but differentiation in vitro toward endothelial cells is poorly understood. Flow cytometry demonstrated that hASCs isolated from excised fat tissue were positive for CD29, CD44, CD70, CD90, CD105, and CD166 and negative for the endothelial marker CD31, and the hematopoietic cell markers CD34 and CD133. hASCs differentiated into adipocytes after cultivation in adipogenic medium. Exposure of hASCs for 10 days under hypoxia (3% oxygen) in combination with leptin increased the percentage of CD31(+) endothelial cells as well as CD31, VE-Cadherin, Flk-1, Tie2, von Willebrand factor, and endothelial cell nitric oxide synthase mRNA expression. This was enhanced on co-incubation of vascular endothelial growth factor (VEGF) and leptin, whereas VEGF alone was not sufficient. Moreover, hASCs cultured on a matrigel surface under hypoxia/VEGF/leptin, showed a stable branching network. Hypoxic conditions significantly decreased apoptosis as evaluated by cleaved caspase-3, and increased prolyl hydroxylase domain 3 mRNA expression. Hypoxia increased expression of VEGF as well as leptin transcripts, which were significantly inhibited on co-incubation with either VEGF or leptin or a combination of both. Furthermore, leptin treatment of hypoxic cells increased the expression of the long/signaling form of the leptin receptor (ObRL), which was augmented on co-incubation with VEGF. The observed endothelial differentiation was dependent on the Akt pathway, as co-administration with Akt inhibitor abolished the observed effects. In conclusion, our data demonstrate that hASCs can be efficiently differentiated to endothelial cells by mimicking the hypoxic and pro-angiogenic microenvironment of adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24134622     DOI: 10.1089/scd.2013.0268

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  17 in total

Review 1.  The increasingly complex regulation of adipocyte differentiation.

Authors:  Sylvia P Poulos; Michael V Dodson; Melinda F Culver; Gary J Hausman
Journal:  Exp Biol Med (Maywood)       Date:  2015-12-07

Review 2.  Vascular Tissue Engineering: Progress, Challenges, and Clinical Promise.

Authors:  H-H Greco Song; Rowza T Rumma; C Keith Ozaki; Elazer R Edelman; Christopher S Chen
Journal:  Cell Stem Cell       Date:  2018-03-01       Impact factor: 24.633

Review 3.  Effect of hypoxia on human adipose-derived mesenchymal stem cells and its potential clinical applications.

Authors:  Jane Ru Choi; Kar Wey Yong; Wan Kamarul Zaman Wan Safwani
Journal:  Cell Mol Life Sci       Date:  2017-02-21       Impact factor: 9.261

4.  Therapeutic Effect of Pericytes for Diabetic Wound Healing.

Authors:  Kyeong Mi Kim; Hyun-Ju An; Sang-Hoon Kim; JuHee Kim; Changgon Sim; Jaemin Lee; Sin Hyung Park; Hyun Il Lee; Inseok Jang; Soonchul Lee
Journal:  Front Cardiovasc Med       Date:  2022-05-13

5.  Priming Dental Pulp Stem Cells With Fibroblast Growth Factor-2 Increases Angiogenesis of Implanted Tissue-Engineered Constructs Through Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Secretion.

Authors:  Caroline Gorin; Gael Y Rochefort; Rumeyza Bascetin; Hanru Ying; Julie Lesieur; Jérémy Sadoine; Nathan Beckouche; Sarah Berndt; Anita Novais; Matthieu Lesage; Benoit Hosten; Laetitia Vercellino; Pascal Merlet; Dominique Le-Denmat; Carmen Marchiol; Didier Letourneur; Antonino Nicoletti; Sibylle Opsahl Vital; Anne Poliard; Benjamin Salmon; Laurent Muller; Catherine Chaussain; Stéphane Germain
Journal:  Stem Cells Transl Med       Date:  2016-01-21       Impact factor: 6.940

6.  Endothelial Differentiation of Human Adipose-Derived Stem Cells on Polyglycolic Acid/Polylactic Acid Mesh.

Authors:  Meng Deng; Yunpeng Gu; Zhenjun Liu; Yue Qi; Gui E Ma; Ning Kang
Journal:  Stem Cells Int       Date:  2015-05-28       Impact factor: 5.443

7.  Non-genetic direct reprogramming and biomimetic platforms in a preliminary study for adipose-derived stem cells into corneal endothelia-like cells.

Authors:  Ying Dai; Yonglong Guo; Chan Wang; Qing Liu; Yan Yang; Shanyi Li; Xiaoling Guo; Ruiling Lian; Rongjie Yu; Hongwei Liu; Jiansu Chen
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

8.  Human Stem Cell-Derived Endothelial-Hepatic Platform for Efficacy Testing of Vascular-Protective Metabolites from Nutraceuticals.

Authors:  Balakrishnan Chakrapani Narmada; Yeek Teck Goh; Huan Li; Sanjay Sinha; Hanry Yu; Christine Cheung
Journal:  Stem Cells Transl Med       Date:  2016-10-07       Impact factor: 6.940

9.  Small Diameter Blood Vessels Bioengineered From Human Adipose-derived Stem Cells.

Authors:  Renpeng Zhou; Lei Zhu; Shibo Fu; Yunliang Qian; Danru Wang; Chen Wang
Journal:  Sci Rep       Date:  2016-10-14       Impact factor: 4.379

Review 10.  The biomolecular basis of adipogenic differentiation of adipose-derived stem cells.

Authors:  Maria Giovanna Scioli; Alessandra Bielli; Pietro Gentile; Donatella Mazzaglia; Valerio Cervelli; Augusto Orlandi
Journal:  Int J Mol Sci       Date:  2014-04-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.